This brand name is authorized in United States
The drug PAREMYD contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Hydroxyamfetamine
UNII 59IG47SZ0E - HYDROXYAMPHETAMINE HYDROBROMIDE
|
|
Hydroxyamphetamine is an indirectly-acting sympathomimetic agent which, when applied topically to the eye, causes the release of endogenous norepinephrine from intact adrenergic nerve terminals resulting in mydriasis. |
|
2
Tropicamide
UNII N0A3Z5XTC6 - TROPICAMIDE
|
|
Tropicamide is an anticholinergic which blocks the responses of the sphincter muscle of the iris and the ciliary muscle to cholinergic stimulation thus dilating the pupil (mydriasis). |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 17478-704 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
